Takahiro Kuno: Management of VTE Across Renal Function and Hemodialysis Status
Takahiro Kuno, Visiting Researcher at The University of Tokyo Hospital, Cardiologist and PhD Candidate at Gunma University Hospital, shared a post on LinkedIn:
“A bit delayed, but I had the privilege of attending ACC.26 in New Orleans last month.
I presented our analysis from the COMMAND VTE Registry-2 examining management and outcomes of venous thromboembolism (VTE) across renal function and hemodialysis status.
A key takeaway: bleeding risk in VTE patients is not driven by eGFR alone—being on hemodialysis itself confers additional bleeding risk, beyond what renal function metrics capture.
This nuance matters when we counsel patients on anticoagulation strategy.
It was also my first time in New Orleans, and the jazz culture was a wonderful surprise.
I’d love to go back.
Grateful to all collaborators in the COMMAND VTE Registry-2 investigators group, and to my mentors for their guidance.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 14:43Abdou Salam Poutougnigni: Honored to Represent Fondation Pierre Fabre at the Africa CDC Sickle Cell Disease Validation Conference
-
May 12, 2026, 14:42Suleiman Malhi at Sundas Foundation with Blood Donation Society on the occasion of World Thalassemia Day
-
May 12, 2026, 14:39Neil Blumberg: Why Washed Red Cell and Platelet Transfusions Deserve More Attention
-
May 12, 2026, 14:34Wajeeha Rashid: Research Poster Award at MedExpo 2.0
-
May 12, 2026, 14:27Intezar Mehdi: When Frequent Nosebleeds Are Not Just a Minor Issue
-
May 12, 2026, 14:22Understanding the Human Side of Hemophilia Gene Therapy – ISTH
-
May 12, 2026, 14:01Moses Wasswa: Tackling Sickle Cell Disease in Uganda
-
May 12, 2026, 13:58Arun Chervu: Most DVT Patients Do Well on Anticoagulation Alone
-
May 12, 2026, 13:49Shashank Joshi: Antiphospholipid Antibodies and Risk of Thrombotic Cardiovascular Events